ENT & Head and Neck Surgery · page 3

Adjuvant checkpoint inhibitors improve survival in resected head and neck cancer, at a real toxicity cost

A meta-analysis of phase III trials finds a 26% reduction in the risk of death when checkpoint inhibitors are added after chemoradiotherapy, elective tracheostomy after head and neck reconstruction protects the airway but costs flaps and feeding, and vitamin D halves recurrent positional vertigo in deficient patients.